Balaxi Pharmaceuticals Reports Nil Physical Share Transfer Re-Lodgements for Sep'26
Balaxi Pharmaceuticals Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 5:45 am
Balaxi Pharmaceuticals Reports Nil Physical Share Transfer Re-Lodgements for Sep'26 Balaxi Pharmaceuticals submitted its RTA report from Aarthi Consultants for the period ended Sep'26 regarding the re-lodgement of physical share transfer requests pursuant to SEBI circular dated 30th Jan'26. The company reported nil requests received, processed, approved, or rejected during the month under the special window.
Original exchange filing (PDF)
More announcements from Balaxi Pharmaceuticals Ltd
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentation 路 16 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated November 12, 2026, titled "Balaxi Pharmaceuticals Limited Reports Strong Q2 FY27 Performance; Revenue Grows 45%, EBITDA Surges 338% and PAT Rises 450% YoY". 路 13 Nov 2026
- Balaxi Pharmaceuticals Limited has informed the Exchange regarding Progress of the Company's Pharmaceutical Formulation Plant at Jadcherla, Hyderabad. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about change in Management 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on November 12, 2026. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding ''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended October 2026". 路 12 Nov 2026
- BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
